These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27166654)

  • 21. Mutations and altered expression of the human cancer genes: what they tell us about causes.
    Devereux TR; Risinger JI; Barrett JC
    IARC Sci Publ; 1999; (146):19-42. PubMed ID: 10353382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation and disregulation of mammalian nucleotide excision repair: a pathway to nongermline breast carcinogenesis.
    Latimer JJ; Majekwana VJ; Pabón-Padín YR; Pimpley MR; Grant SG
    Photochem Photobiol; 2015; 91(2):493-500. PubMed ID: 25393451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Putting poly (ADP-ribose) polymerase and other DNA repair inhibitors into clinical practice.
    Helleday T
    Curr Opin Oncol; 2013 Nov; 25(6):609-14. PubMed ID: 24097104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary immunodeficiency syndromes associated with defective DNA double-strand break repair.
    Gennery AR
    Br Med Bull; 2006; 77-78():71-85. PubMed ID: 16971555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic deregulation of DNA repair and its potential for therapy.
    Hegi ME; Sciuscio D; Murat A; Levivier M; Stupp R
    Clin Cancer Res; 2009 Aug; 15(16):5026-31. PubMed ID: 19671858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical detection of mismatch repair gene proteins as a useful tool for the identification of colorectal carcinoma with the mutator phenotype.
    Chaves P; Cruz C; Lage P; Claro I; Cravo M; Leitão CN; Soares J
    J Pathol; 2000 Aug; 191(4):355-60. PubMed ID: 10918209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance.
    Zhu Y; Hu J; Hu Y; Liu W
    Cancer Treat Rev; 2009 Nov; 35(7):590-6. PubMed ID: 19635647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA damage in cancer therapeutics: a boon or a curse?
    Khanna A
    Cancer Res; 2015 Jun; 75(11):2133-8. PubMed ID: 25931285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutator pathways unleashed by epigenetic silencing in human cancer.
    Jacinto FV; Esteller M
    Mutagenesis; 2007 Jul; 22(4):247-53. PubMed ID: 17412712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolutionary dynamics and significance of multiple subclonal mutations in cancer.
    Beckman RA; Loeb LA
    DNA Repair (Amst); 2017 Aug; 56():7-15. PubMed ID: 28652129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.
    de Boer J; van Steeg H; Berg RJ; Garssen J; de Wit J; van Oostrum CT; Beems RB; van der Horst GT; van Kreijl CF; de Gruijl FR; Bootsma D; Hoeijmakers JH; Weeda G
    Cancer Res; 1999 Jul; 59(14):3489-94. PubMed ID: 10416615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA damage response--a double-edged sword in cancer prevention and cancer therapy.
    Tian H; Gao Z; Li H; Zhang B; Wang G; Zhang Q; Pei D; Zheng J
    Cancer Lett; 2015 Mar; 358(1):8-16. PubMed ID: 25528631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Synthetic lethality as a new concept for the treatment of cancer].
    Herter-Sprie GS; Chen S; Höpker K; Reinhardt HC
    Dtsch Med Wochenschr; 2011 Jul; 136(30):1526-30. PubMed ID: 21789751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Replication error repair, microsatellites, and cancer].
    Duval A; Hamelin R
    Med Sci (Paris); 2003 Jan; 19(1):55-62. PubMed ID: 12836192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients.
    Chistiakov DA; Voronova NV; Chistiakov PA
    Acta Oncol; 2008; 47(5):809-24. PubMed ID: 18568480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of endogenous oxidative DNA damage in carcinogenesis: what can we learn from repair-deficient mice?
    Epe B
    Biol Chem; 2002; 383(3-4):467-75. PubMed ID: 12033436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 8-Hydroxyguanosine repair is defective in some microsatellite stable colorectal cancer cells.
    Parker AR; O'Meally RN; Oliver DH; Hua L; Nelson WG; DeWeese TL; Eshleman JR
    Cancer Res; 2002 Dec; 62(24):7230-3. PubMed ID: 12499263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nomadic genetic elements contribute to oncogenic translocations: Implications in carcinogenesis.
    Dhivya S; Premkumar K
    Crit Rev Oncol Hematol; 2016 Feb; 98():81-93. PubMed ID: 26548742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RAS/RAF mutation and defective DNA mismatch repair in endometrial cancers.
    Mutch DG; Powell MA; Mallon MA; Goodfellow PJ
    Am J Obstet Gynecol; 2004 Apr; 190(4):935-42. PubMed ID: 15118616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting homologous recombination, new pre-clinical and clinical therapeutic combinations inhibiting RAD51.
    Ward A; Khanna KK; Wiegmans AP
    Cancer Treat Rev; 2015 Jan; 41(1):35-45. PubMed ID: 25467108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.